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A study on presence of antibodies to Trichomonis vaginalis in serum was done on a group
of 500 pregnant, asymptomatic Angolan women. A serologic screening, done by ELISA,
revealed that 41% of the women had IgG and IgM against the parasite. Analysis of sera by
immunoblotting revealed that 94.4% of sera with anti-T. vaginalis IgG class antibodies were
reactive against a common immunogenic protein of 115 kDa. The common immunogen was
identified as the protozoan a-actinin. All sera recognizing the 115-kDa antigen were reactive
against both native and recombinant T. vaginalis a-actinin and nonreactive against human a-
actinin. The findings presented in this work offer a new tool for epidemiologic studies and
open new perspectives for vaccination.
Trichomoniasis is the most diffused nonviral sexually trans-
mitted disease worldwide [1], characterized by a severe discom-
fort with inflammation and abdominal pain [2], although the
infection may often be asymptomatic, leading to underesti-
mation of the disease diffusion. During pregnancy, trichomo-
niasis can lead to adverse pregnancy outcome, manifested with
preterm delivery and low birth weight [3]. Trichomonas vaginalis
induces humoral, secretory, and cellular immune responses in
infected individuals [4]. Several studies, aimed at characterizing
prominent immunogens [5], have assessed the high degree of
antigenic heterogeneity and phenotypic variability of the par-
asite. The humoral response seems to be directed mainly against
common determinants [4], but most of them have not yet been
clearly identified and characterized. Moreover, most of the pre-
vious studies had been performed by using a low number of
samples, all of which had been obtained from women with an
active trichomonad infection.
To identify the common immunogens, we performed a se-
rologic study in a highly endemic area for trichomoniasis over
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a wide group of pregnant women, enrolled independently be-
cause of symptoms of vaginal infection.
Materials and Methods
Cell cultures, organisms, and patients. Human fibroblasts (from
human embryonic lung), recombinant Escherichia coli cells, and 11
T. vaginalis clinical isolates were cultured, as described elsewhere
[6]. A group of 500 pregnant asymptomatic women aged 15–40
years attending the Lucrecia Paim Hospital in Luanda, Angola,
was enrolled for this study. All women were subjected to standard
clinical examination, and vaginal samples were collected, examined
for presence of T. vaginalis by wet mount, and processed for iden-
tification of vaginal microorganisms. A 10-mL blood sample was
collected from each patient. Ten sera from women with acute trich-
omoniasis and 10 sera from healthy male volunteers were collected
in Italy.
ELISA. ELISA was done according to the method reported
by Alderete [7]. Isolate SS-22, which is not infected by Mycoplasma
hominis [8], was chosen as source of antigen to avoid nonspecific
antimycoplasma reactivities. All sera were tested for presence of
IgG or IgM against the parasite at a dilution of 1 : 50 in PBS plus
5% nonfat dry milk (blotto). Sera were classified as negative if the
ELISA optical densities (ODs) in the wells were lower than the
cutoff value, which was established as twice the mean value ob-
tained with sera from 10 healthy male volunteers; as weakly positive
if OD was 2–3 times the cutoff value; as intermediate if OD was
13–4 times the cutoff value; and as strongly positive if OD was 14
times the cutoff value.
SDS-PAGE and Western blotting. Total T. vaginalis SS-22 pro-
tein preparations were obtained by trichloroacetic acid precipita-
tion [9], electrophoresed by SDS-PAGE, and transferred onto a
nitrocellulose membrane, which was probed with 500 mL of each
diluted serum. All Angolan sera and the 10 sera from Italian women
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Figure 1. Immunoblot patterns of 8 representative Angolan sera
with high IgG response obtained by probing a total Trichomonas va-
ginalis trichloracetic acid protein preparation. Molecular weight mark-
ers are shown on the left. The arrow points to the common 115-kDa
antigen.
affected by trichomoniasis were diluted in blotto as follows: 1 :
200 for weak, 1 : 300 for intermediate, and 1 : 400 for strongly
positive sera. As a control, 20 sera from Angolan women negative
for T. vaginalis by both ELISA and wet-mount but positive for
other sexually transmitted diseases (STDs), including candidiasis,
syphilis, gonorrhea, hepatitis B, and AIDS, and 10 sera from
healthy Italian male volunteers were tested at a dilution of 1 : 100.
After incubation, membranes were washed and incubated with anti-
human IgG or IgM rabbit immunoglobulins conjugated with al-
kaline phosphatase (Sigma, St. Louis). Bound antibodies were de-
tected with chromogenic substrates.
Detection of T. vaginalis recombinant and native a-actinin with
human sera. Recombinant T. vaginalis a-actinin was obtained as
described elsewhere [10]. Immunoprecipitation of the native T. va-
ginalis a-actinin was performed according to standard procedures
[11]. Total proteins from E. coli expressing the recombinant a-
actinin and the native, immunoprecipitated protein were electro-
phoresed and transferred onto nitrocellulose. The membranes were
both probed with 20 sera positive for the 115-kDa T. vaginalis
antigen and 10 ELISA-negative sera. After 2 h of incubation, mem-
branes were incubated with secondary anti-IgG antibodies for 1 h.
Bound antibodies were then detected as described earlier. Prior to
use, the human sera were preadsorbed with E. coli total proteins.
Competition and cross-reactivity studies. Six nitrocellulose lanes
containing the native immunoprecipitated T. vaginalis a-actinin,
transferred as described, were incubated with 3 human sera positive
for anti–115-kDa T. vaginalis antigen or with 3 negative human
sera. After 2 h, the membranes were incubated with rabbit anti–T.
vaginalis a-actinin antibodies. After another 2 h, the membranes
were incubated for 1 h with anti-rabbit secondary antibodies.
The experiment was also performed by inverting the incubation
order of rabbit and human antibodies. Membranes were first in-
cubated for 2 h with rabbit anti–T. vaginalis a-actinin antibodies.
The 3 115-kDa–positive or the 3 negative human sera were then
applied and incubated for 2 h. Anti-human IgG secondary anti-
bodies were then added and incubated for 1 h. As a control, another
lane was probed only with rabbit anti–T. vaginalis a-actinin anti-
bodies, a second lane only with a T. vaginalis–positive human se-
rum, and a third lane only with a negative human serum. After 4
h, the membranes were incubated with the respective secondary
antibodies and then treated for detection of bound antibodies.
To assess absence of cross-reactivity of the anti–T. vaginalis a-
actinin antibodies with human a-actinin, a total of tryp-65 3 10
sinized, washed human embryonic lung cells were subjected to SDS-
PAGE and transferred onto a nitrocellulose filter, which was in-
cubated for 2 h with 10 anti–T.vaginalis–positive sera, 10 negative
sera, and commercial anti–a-actinin antibodies (Sigma). After
washing, secondary antibodies were added to the wells and incu-
bated for 1 h. The filter was then washed and developed.
Results
T. vaginalis organisms were microscopically observed in 78
of 500 vaginal samples, corresponding to 15%. Among all 500
sera, 203 (41%) tested positive by use of the ELISA test: 108
of them had IgG (53%), 61 had IgM (30%), and 36 (17%) had
both. Among the 78 women who tested positive by the wet-
mount test, the percentage of seropositivity rose to 86% (67
women). In this case, 43 (64%) had IgG, 10 (15%) had IgM,
and 14 (21%) had both. No positive correlation was found
between antibody titer or immunoglobulin class and wet-mount
positivity.
The antibody specificity was investigated by immunoblotting.
We observed that 94.4% of the 144 IgG-positive sera recognized
a T. vaginalis protein weighing 115 kDa. The percentage rose
to 98% in women positive by use of the wet-mount test. Another
common immunogen, weighing ∼140 kDa, was detected in
76.8% of all sera and 90.3% of sera from women positive by
the wet-mount test. A specific reactivity against the 115-kDa
polypeptide was also detected in 9 of 10 sera from Italian pa-
tients with trichomoniasis. The 115- and 140-kDa common im-
munogens were expressed by all 10 T. vaginalis isolates of dif-
ferent geographic origin that were tested. Reactivity against a
number proteins of lower molecular weight was also observed,
but it showed a high sera-to-sera variability (figure 1).
Less selective reactivities were observed by using IgM-posi-
tive sera: ∼50% of sera were reactive against an antigen weigh-
ing 40 kDa. Presence of an antigen of this molecular weight
recognized by IgM in sera of infected patients is consistent with
results of previous studies [5]. Our group had recently cloned
the T. vaginalis a-actinin [10]. Because this protein has the same
molecular weight as the prominent 115-kDa antigen, is con-
stantly expressed, and is present in all isolates, we investigated
whether there was identity between the 2 proteins. All 115-kDa
antigen-positive human sera tested recognized the recombinant
a-actinin, whereas all negative controls did not. No reactivity
was observed against the recombinant E. coli lacking the T.
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Figure 2. Representative blots showing the 2 competition experi-
ments performed on immunoprecipitated native Trichomonas vaginalis
a-actinin. Lanes 1 and 2 represent the immunoblot pattern obtained,
respectively, with rabbit anti–T. vaginalis a-actinin antibodies and with
a 115-kDa–positive human serum, whereas the third lanes represent
the result of the competition between the 2 antibodies. A, lane 1: rabbit
anti–T. vaginalis a-actinin antibodies; lane 2: positive human serum;
lane 3: rabbit anti–T. vaginalis a-actinin antibodies followed by positive
human serum and then by anti-human IgG immunoglobulins. B, lane
1: rabbit anti–T. vaginalis a-actinin antibodies; lane 2: positive human
serum; lane 3: positive human serum followed by rabbit anti–T. va-
ginalis a-actinin antibodies and then by anti-rabbit immunoglobulins.
For details, see Materials and Methods. The arrow points to T. vaginalis
a-actinin.
vaginalis a-actinin cDNA. The same results were obtained with
the native T. vaginalis a-actinin.
To further confirm the identity between T. vaginalis a-actinin
and the 115-kDa T. vaginalis antigen, immunoprecipitated na-
tive protozoan a-actinin was used for a competition experiment
among 115-kDa antigen–reactive human sera and monospecific
rabbit anti–T. vaginalis a-actinin antibodies. Preincubation of
T. vaginalis a-actinin with the rabbit antibodies abolished bind-
ing of the positive human sera (figure 2A, lane 3). Moreover,
when T. vaginalis a-actinin was preincubated with the 115-
kDa–positive human sera, binding of rabbit antibodies was
abolished as well (figure 2B, lane 3), whereas preincubation
with negative human sera did not abolish binding of anti-a-
actinin rabbit antibodies. This indicated a competition between
human antibodies specific for the common 115-kDa antigen
and rabbit anti-T. vaginalis a-actinin antibodies, therefore con-
firming the identity of the 115-kDa common antigen as the
protozoan a-actinin.
We recently observed that anti–T. vaginalis a-actinin rabbit
antibodies are not reactive with the human form of the protein
or with cytoskeletal proteins from other parasites [10]. This
observation led us to investigate whether anti–T. vaginalis a-
actinin antibodies in human sera are directed against epitopes
absent in human a-actinin. Therefore, human sera showing a
positive reaction with both recombinant and native T. vaginalis
a-actinin were probed with human fibroblast total proteins. The
sera tested failed to recognize the human form of a-actinin,
readily recognized by commercial anti–a-actinin antibodies.
Discussion
To identify the parasite proteins that elicit a common hu-
moral response in people exposed to the parasite, we analyzed
a group of 500 sera obtained from pregnant women living in
a highly endemic area for STDs, including trichomoniasis. A
screening by ELISA revealed a 41% seropositivity for IgG and
IgM. No positive correlation was found between presence of
IgM antibodies and wet-mount positivity; presence of anti–T.
vaginalis immunoglobulins in serum appears to have no rela-
tionship with a current parasite infection and therefore seems
not to be useful for diagnosis.
Western blotting analysis revealed that 94% of the IgG-pos-
itive sera reacted against a protozoan protein weighing 115
kDa. This percentage rose to 98% when sera of women positive
by use of the wet-mount test were considered. Presence of a
common antigenic molecule with this molecular weight is con-
sistent with findings from previous reports [5, 12]. The 115-kDa
antigen was identified as the protozoan a-actinin [10, 13]. Iden-
tification of a-actinin as a common immunogen has important
implications, because it is a structural protein, is constantly
expressed during parasite life, is present in all isolates, and does
not undergo geographic variation.
As reported elsewhere [10–14], a-actinin is constantly ob-
served on the surface of epithelial cells lysed by the parasite
and thus is exposed to immunologic recognition; this might
explain the high antibody response observed against this in-
tracellular protein. It seems intriguing to observe that the com-
mon immunogen seen on 70% of sera has a molecular weight
of 140 kDa, corresponding to that of another T. vaginalis pro-
tein observed to bind to target cells [14].
In rabbits immunized with total parasite proteins, a-actinin
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elicits an important humoral immune response [10]. The com-
petition assay performed in this work revealed that rabbit and
human anti–T. vaginalis a-actinin antibodies are directed
against the same epitopes on the protein. These are unique to
the protozoan a-actinin; in fact, anti–T. vaginalis antibodies
present in human sera do not react with the human form of
the protein.
The immunogenicity of T. vaginalis a-actinin and the lack of
serologic reactivity against the human form are consistent with
the molecular structure [10, 13]: in fact, the homology with
other a-actinins is not found in the central region of the mol-
ecule, which also contains 3 high immunogenic regions [10].
Further studies could be performed to show whether multiple
isoforms of this gene exist; in fact, some T. vaginalis proteins
are encoded by slightly divergent genes [2].
No humoral response against the parasite protein is detect-
able in sera obtained from healthy donors or from women
affected by vaginal infections other than trichomoniasis; pres-
ence of anti–T. vaginalis a-actinin IgGs in serum can therefore
be considered a good epidemiologic marker. Further studies on
this common immunogen, such as the subcloning of the highly
immunogenic peptides located on the central region of the pro-
tein, might represent a starting point for designing a new vac-
cine strategy for prevention of trichomoniasis [15] or for se-
rologic studies on diffusion of this widespread STD.
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